論文 - 詳細
| RRC ID | 36274 |
|---|---|
| 著者 | Nikaido Y, Kurosawa A, Saikawa H, Kuroiwa S, Suzuki C, Kuwabara N, Hoshino H, Obata H, Saito S, Saito T, Osada H, Kobayashi I, Sezutsu H, Takeda S. |
| タイトル | In vivo and in vitro evaluation of novel μ-opioid receptor agonist compounds. |
| ジャーナル | Eur J Pharmacol |
| Abstract |
Opioids are the most effective and widely used drugs for pain treatment. Morphine is an archetypal opioid and is an opioid receptor agonist. Unfortunately, the clinical usefulness of morphine is limited by adverse effects such as analgesic tolerance and addiction. Therefore, it is important to study the development of novel opioid agonists as part of pain control. The analgesic effects of opioids are mediated by three opioid receptors, namely opioid μ-, δ-, and κ-receptors. They belong to the G protein-coupled receptor superfamily and are coupled to Gi proteins. In the present study, we developed a ligand screening system to identify novel opioid μ-receptor agonists that measures [(35)S]GTPγS binding to cell membrane fractions prepared from the fat body of transgenic silkworms expressing μ-receptor-Gi1α fusion protein. We screened the RIKEN Natural Products Depository (NPDepo) chemical library, which contains 5848 compounds, and analogs of hit compounds. We successfully identified a novel, structurally unique compound, that we named GUM1, with agonist activity for the opioid μ-receptor (EC50 of 1.2 µM). The Plantar Test (Hargreaves' Method) demonstrated that subcutaneous injection of 3mg/kg of GUM1 into wild-type rats significantly extended latency time. This extension was also observed in a rat model of morphine tolerance and was inhibited by pre-treatment of naloxone. The unique molecular skeleton of GUM1 makes it an attractive molecule for further ligand-opioid receptor binding studies. |
| 巻・号 | 767 |
| ページ | 193-200 |
| 公開日 | 2015-11-15 |
| DOI | 10.1016/j.ejphar.2015.10.025 |
| PII | S0014-2999(15)30306-X |
| PMID | 26476280 |
| MeSH | Analgesics, Opioid / agonists Analgesics, Opioid / pharmacology Animals Animals, Genetically Modified Benzylamines / agonists* Benzylamines / pharmacology* Biological Products / pharmacology* Bombyx Drug Tolerance Guanosine 5'-O-(3-Thiotriphosphate) / metabolism Humans Male Pain Measurement / drug effects Pyrans / agonists* Pyrans / pharmacology* Radioligand Assay Rats Receptors, Opioid, mu / agonists* Receptors, Opioid, mu / genetics Sulfur Radioisotopes / metabolism |
| IF | 3.263 |
| 引用数 | 6 |
| WOS 分野 | PHARMACOLOGY & PHARMACY |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 3 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| カイコ | |